Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
6145 | 1522 | 28.2 | 49% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
11 | 4 | NEUROSCIENCES//CLINICAL NEUROLOGY//NEUROL | 1112395 |
143 | 3 | EPILEPSY//EPILEPSIA//EPILEPSY & BEHAVIOR | 64226 |
230 | 2 | ANTIEPILEPTIC DRUGS//LEVETIRACETAM//EPILEPSY | 20331 |
6145 | 1 | CARBAMAZEPINE 10 11 EPOXIDE//CARBAMAZEPINE//THERAPEUTIC DRUG MONITORING | 1522 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | CARBAMAZEPINE 10 11 EPOXIDE | authKW | 391423 | 2% | 51% | 38 |
2 | CARBAMAZEPINE | authKW | 374130 | 14% | 9% | 215 |
3 | THERAPEUTIC DRUG MONITORING | journal | 255530 | 14% | 6% | 218 |
4 | PHENYTOIN | authKW | 202359 | 8% | 8% | 120 |
5 | FREE PHENYTOIN | authKW | 180543 | 1% | 75% | 12 |
6 | CARBAMAZEPINE EPOXIDE | authKW | 65525 | 0% | 47% | 7 |
7 | CARBAMAZEPINE 10 11 DIOL | authKW | 60183 | 0% | 100% | 3 |
8 | FREE DIGITOXIN | authKW | 60183 | 0% | 100% | 3 |
9 | FREE VALPROIC ACID | authKW | 60183 | 0% | 100% | 3 |
10 | SHEINER TOZER EQUATION | authKW | 60183 | 0% | 100% | 3 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Medical Laboratory Technology | 19197 | 19% | 0% | 285 |
2 | Pharmacology & Pharmacy | 14148 | 56% | 0% | 850 |
3 | Toxicology | 4430 | 17% | 0% | 253 |
4 | Clinical Neurology | 2045 | 17% | 0% | 260 |
5 | Chemistry, Analytical | 560 | 10% | 0% | 146 |
6 | Medicine, General & Internal | 133 | 6% | 0% | 92 |
7 | Biochemical Research Methods | 81 | 3% | 0% | 52 |
8 | Psychiatry | 71 | 4% | 0% | 55 |
9 | Pediatrics | 53 | 3% | 0% | 47 |
10 | Chemistry, Medicinal | 35 | 2% | 0% | 34 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | HORMONOL THER EUT DRUG MONITORING | 26747 | 0% | 67% | 2 |
2 | ACUTE CARE STREAM | 20061 | 0% | 100% | 1 |
3 | ASSURANCE QUAL S ANAL BIOL MED | 20061 | 0% | 100% | 1 |
4 | BIOCHIM PHARMACOL TOXICOL TRACES | 20061 | 0% | 100% | 1 |
5 | CATEDRA TOXICOL BIOQUIM | 20061 | 0% | 100% | 1 |
6 | CENT MED BIOCHEM | 20061 | 0% | 100% | 1 |
7 | CHEM EVORA CQE | 20061 | 0% | 100% | 1 |
8 | CHEM TECHNOL ANALYTI CHEM | 20061 | 0% | 100% | 1 |
9 | CLIN CLIN PHARMACOLTOYAMA CHO 1 | 20061 | 0% | 100% | 1 |
10 | CLIN PHARMACOKINET CONSULTAT SERV | 20061 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | THERAPEUTIC DRUG MONITORING | 255530 | 14% | 6% | 218 |
2 | CLINICAL PHARMACOKINETICS | 21244 | 3% | 2% | 50 |
3 | EPILEPSIA | 13272 | 5% | 1% | 77 |
4 | JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS | 9532 | 2% | 1% | 32 |
5 | BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 7413 | 4% | 1% | 55 |
6 | CLINICAL PHARMACY | 5863 | 1% | 2% | 15 |
7 | EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 3040 | 2% | 0% | 33 |
8 | INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS | 2928 | 2% | 1% | 24 |
9 | CLINICAL PHARMACOLOGY & THERAPEUTICS | 2468 | 2% | 0% | 27 |
10 | BIOPHARMACEUTICS & DRUG DISPOSITION | 2318 | 1% | 1% | 15 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CARBAMAZEPINE 10 11 EPOXIDE | 391423 | 2% | 51% | 38 | Search CARBAMAZEPINE+10+11+EPOXIDE | Search CARBAMAZEPINE+10+11+EPOXIDE |
2 | CARBAMAZEPINE | 374130 | 14% | 9% | 215 | Search CARBAMAZEPINE | Search CARBAMAZEPINE |
3 | PHENYTOIN | 202359 | 8% | 8% | 120 | Search PHENYTOIN | Search PHENYTOIN |
4 | FREE PHENYTOIN | 180543 | 1% | 75% | 12 | Search FREE+PHENYTOIN | Search FREE+PHENYTOIN |
5 | CARBAMAZEPINE EPOXIDE | 65525 | 0% | 47% | 7 | Search CARBAMAZEPINE+EPOXIDE | Search CARBAMAZEPINE+EPOXIDE |
6 | CARBAMAZEPINE 10 11 DIOL | 60183 | 0% | 100% | 3 | Search CARBAMAZEPINE+10+11+DIOL | Search CARBAMAZEPINE+10+11+DIOL |
7 | FREE DIGITOXIN | 60183 | 0% | 100% | 3 | Search FREE+DIGITOXIN | Search FREE+DIGITOXIN |
8 | FREE VALPROIC ACID | 60183 | 0% | 100% | 3 | Search FREE+VALPROIC+ACID | Search FREE+VALPROIC+ACID |
9 | SHEINER TOZER EQUATION | 60183 | 0% | 100% | 3 | Search SHEINER+TOZER+EQUATION | Search SHEINER+TOZER+EQUATION |
10 | CARBAMAZEPINE DIOL | 45136 | 0% | 75% | 3 | Search CARBAMAZEPINE+DIOL | Search CARBAMAZEPINE+DIOL |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | KONG, ST , LIM, SH , CHAN, E , HO, PC , (2014) ESTIMATION AND COMPARISON OF CARBAMAZEPINE POPULATION PHARMACOKINETICS USING DRIED BLOOD SPOT AND PLASMA CONCENTRATIONS FROM PEOPLE WITH EPILEPSY: THE CLINICAL IMPLICATION.JOURNAL OF CLINICAL PHARMACOLOGY. VOL. 54. ISSUE 2. P. 225-233 | 30 | 79% | 7 |
2 | BATTINO, D , ESTIENNE, M , AVANZINI, G , (1995) CLINICAL PHARMACOKINETICS OF ANTIEPILEPTIC DRUGS IN PEDIATRIC-PATIENTS .2. PHENYTOIN, CARBAMAZEPINE, SULTHIAME, LAMOTRIGINE, VIGABATRIN, OXCARBAZEPINE AND FELBAMATE.CLINICAL PHARMACOKINETICS. VOL. 29. ISSUE 5. P. 341-369 | 58 | 67% | 55 |
3 | RIVA, R , ALBANI, F , CONTIN, M , BARUZZI, A , (1996) PHARMACOKINETIC INTERACTIONS BETWEEN ANTIEPILEPTIC DRUGS - CLINICAL CONSIDERATIONS.CLINICAL PHARMACOKINETICS. VOL. 31. ISSUE 6. P. 470-493 | 68 | 48% | 112 |
4 | LEVINE, M , CHANG, T , (1990) THERAPEUTIC DRUG-MONITORING OF PHENYTOIN - RATIONALE AND CURRENT STATUS.CLINICAL PHARMACOKINETICS. VOL. 19. ISSUE 5. P. 341-358 | 59 | 78% | 41 |
5 | YUKAWA, E , (1996) OPTIMISATION OF ANTIEPILEPTIC DRUG THERAPY - THE IMPORTANCE OF SERUM DRUG CONCENTRATION MONITORING.CLINICAL PHARMACOKINETICS. VOL. 31. ISSUE 2. P. 120-130 | 47 | 75% | 29 |
6 | KIANG, TKL , ENSOM, MHH , (2016) A COMPREHENSIVE REVIEW ON THE PREDICTIVE PERFORMANCE OF THE SHEINER-TOZER AND DERIVATIVE EQUATIONS FOR THE CORRECTION OF PHENYTOIN CONCENTRATIONS.ANNALS OF PHARMACOTHERAPY. VOL. 50. ISSUE 4. P. 311 -325 | 21 | 88% | 0 |
7 | PATSALOS, PN , BERRY, DJ , BOURGEOIS, BFD , CLOYD, JC , GLAUSER, TA , JOHANNESSEN, SI , LEPPIK, IE , TOMSON, T , PERUCCA, E , (2008) ANTIEPILEPTIC DRUGS - BEST PRACTICE GUIDELINES FOR THERAPEUTIC DRUG MONITORING: A POSITION PAPER BY THE SUBCOMMISSION ON THERAPEUTIC DRUG MONITORING, ILAE COMMISSION ON THERAPEUTIC STRATEGIES.EPILEPSIA. VOL. 49. ISSUE 7. P. 1239 -1276 | 71 | 21% | 249 |
8 | POWELL, G , SAUNDERS, M , RIGBY, A , MARSON, AG , (2014) IMMEDIATE-RELEASE VERSUS CONTROLLED-RELEASE CARBAMAZEPINE IN THE TREATMENT OF EPILEPSY.COCHRANE DATABASE OF SYSTEMATIC REVIEWS. VOL. . ISSUE 12. P. - | 19 | 95% | 0 |
9 | BERTILSSON, L , TOMSON, T , (1986) CLINICAL PHARMACOKINETICS AND PHARMACOLOGICAL EFFECTS OF CARBAMAZEPINE AND CARBAMAZEPINE-10,11-EPOXIDE - AN UPDATE.CLINICAL PHARMACOKINETICS. VOL. 11. ISSUE 3. P. 177-198 | 50 | 72% | 212 |
10 | JIAO, Z , SHI, XJ , ZHAO, ZG , ZHONG, MK , (2004) POPULATION PHARMACOKINETIC MODELING OF STEADY STATE CLEARANCE OF CARBAMAZEPINE AND ITS EPOXIDE METABOLITE FROM SPARSE ROUTINE CLINICAL DATA.JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS. VOL. 29. ISSUE 3. P. 247-256 | 25 | 89% | 16 |
Classes with closest relation at Level 1 |